MedPath

Effect of Vyaghrihareetaki Avaleha and Granules on Tamaka Shwasa (Bronchial Asthma)

Phase 2
Completed
Conditions
Health Condition 1: null- Tamaka shwasaBronchial asthma
Registration Number
CTRI/2011/12/002204
Lead Sponsor
Institute for Post Graduate Teaching and Research in Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

1. Patients having signs and symptoms of Tamaka Shwasa as described in Ayurvedic classics.

2. Mild persistent cases of Asthma (as per WHO GINA Guideline) of duration more than 6 months.

3. Symptoms/exacerbation (Wheeze, cough and breathlessness) more than once a week but less than once a day in frequency

Exclusion Criteria

1.Age more than 60 years and below 16 years.

2.Mild intermittent, Moderated persistent, severe persistent to severe Asthma.

3.Dyspnoea resulting from other diseases like left ventricular failure, COPD (Chronic Bronchitis, Emphysema), upper respiratory tract obstruction, bronchiectasis, cases of tuberculosis, interstitial lung disease/occupational lung disease, tropical pulmonary eosinophilia & allergic bronchopulmonary aspergillosis etc.

4.Patients having anaemia, pneumonia, tuberculosis, lung cancer, lung abscess and other such complicated conditions.

5.Patients having diabetes, hypertension, Chronic and Acute renal failure etc. conditions in which urination is markedly diminished or excessive were excluded.

6.HIV positive cases.

7.Pregnant/lactating mother.

8.Patients having classical symptoms of Maha, Urdha, Chinna and Kshudra Shwasa.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Changes in the cardinal symptoms of Tamaka shwasa. <br/ ><br>2. Changes in ACQ and ACT score and PEFR.Timepoint: 0, 4 weeks
Secondary Outcome Measures
NameTimeMethod
Respiratory rate and Breath holding timeTimepoint: 0, 4 weeks
© Copyright 2025. All Rights Reserved by MedPath